Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776422

O=C(CCc1cnoc1-c1ccc(C(F)(F)F)cc1)Nc1ccc2ncccc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 13/20 0.46
PABPC1 P11940 1/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5770756 0.92 HDAC6 (0.42) PABPC1HDAC6HDAC3HDAC4HDAC1
SCHEMBL5775546 0.88 PABPC1 (0.50) PABPC1HDAC6HDAC3HDAC4HDAC1
SCHEMBL5776350 0.86 MAPT (0.51) MCHR1HDAC6HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL5772665 0.83 NPC1 (0.52) HDAC6HDAC4ALDH1A1MAPTNPC1
Trifluoroacetic Acid SCHEMBL5771101 0.83 TP53 (0.46) HDAC6HDAC4ALDH1A1CYP1A2CYP3A4
Trifluoroacetic Acid SCHEMBL5775470 0.83 CNR2 (0.52) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL5773606 0.81 MAPT (0.48) HDAC1ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL5774003 0.80 MGLL (0.50) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL5775672 0.79 MAPT (0.50) MCHR1ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL5776826 0.79 CNR2 (0.48) MCHR1ALDH1A1CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MCHR1 2026/4885PABPC1 4824/4885HDAC6 1324/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MCHR1 2036/4885PABPC1 4594/4885HDAC6 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.